Prevention of Type 1 Diabetes: Is Now the Time?

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 498-506

  Becker, Dorothy J ^a   LaPorte, Ronald E ^a   Libman, Ingrid ^a   Pietropaolo, Massimo ^a   Dosch, Hans Michael ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011484624     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.85.2.6406-3     Document Type: Article

References (123)

1. Bach JF. 1994 Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 15:516-542.
2. Fox CJ, Danska JS. 1997 IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol. 158:2414-2424.
3. Wong FS, Karttunen J, Dumont C, et al. 1999 Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library (see comments). Nat Med. 5:1026-1031.
4. Shimada A, Imazu Y, Morinaga S, et al. 1999 T-cell insulitis found in anti-GAD651 diabetes with residual b-cell function. Diabetes Care. 22:615-617.
5. Bottazzo GF, Florin-Christensen A, Doniach D. 1974 Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 2:1279-1283.
6. Lipton RB, Atchison J, Dorman JS, et al. 1992 Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families. Diabetes Med. 9:224-232.
7. Kuller LH, Becker DJ, Cruickshanks KJ, et al. 1990 Evolution of the Pittsburgh studies of the epidemiology of insulin-dependent diabetes mellitus. Pittsburgh Diabetes Epidemiology and Etiology Research Group. Genet Epidemiol. 7:105-119.
8. Lipton RB, Kocova M, LaPorte RE, et al. 1992 Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am J Epidemiol. 136:503-512.
9. Pietropaolo M, Becker DJ, Dorman JS, et al. 1999 Are GAD65 and IA-2 auto antibodies sufficient to predict type 1 diabetes? Diabetes. 48:A45.
10. Bingley PJ, Christie MR, Bonifacio E, et al. 1994 Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 43:1304-1310.
11. Bingley PJ. 1996 Interactions of age, islet cell antibodies, insulin auto antibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA1 relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes. 45:1720-1728.
12. Nepom GT. 1993 Immuno genetics and IDDM. Diabetes Rev. 1:93-103.
13. Sheehy MJ. 1992 HLA and insulin-dependent diabetes. A protective perspective. Diabetes. 41:123-129.
14. Ettinger RA, Liu AW, Nepom GT, Kwok WW. 1998 Exceptional stability of the HLA-DQA1*0102/DQB1*0602 α β protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus. J Immunol. 161:6439-6445.
15. DPT-1 Study Group. 1995 The Diabetes Prevention Trial-type 1 diabetes (DPT-1): implementation of screening and staging of relatives. Transplant Proc. 27:337.
16. Muir A, Schatz D. 1995 Prevention of insulin-dependent diabetes-1995. Trends Endocrinol Metab. 6:312-317.
17. Knip M, Akerblom HK. 1998 IDDM prevention trials in progress-a critical assessment. J Pediatr Endocrinol Metab. 11:371-377.
18. Vardi P, Brik R, Barzilai D. 1991 Insulin auto antibodies: reflection of disturbed self-identification and their use in the prediction of type I diabetes. Diabetes Metab Rev. 7:209-222.
19. Vardi P, Crisa L, Jackson RA, et al. 1991 Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia. 34:93-102:1991.
20. Arslanian S, Becker DJ, Rabin B, et al. 1985 Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes prior to therapy. Diabetes. 34:926-930.
21. Riley WJ, Maclaren NK, Krischer J, et al. 1990 A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Eng J Med. 232:1167-1172.
22. Verge CF, Gianani R, Kawasaki E, et al. 1996 Prediction of type 1 diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA 512bdc/IA-2 auto antibodies. Diabetes. 45:926-933.
23. Leslie RDG, Atkinson MA, Notkins AL. 1999 Auto antigens IA-2 and GAD in Type 1 (insulin-dependent) diabetes. Diabetologia. 42:3-14.
24. Becker D, Cakan N, LaPorte R, Drash A, Trucco M. 1995 High risk DQ alleles improve IDDM prediction in ICA+ve first-degree relatives with decreased insulin secretion. Diabetologia. 38(Suppl 1):A42.
25. Pietropaolo M, Trucco M, Cakan N, Drash AL, LaPorte RE, Becker DJ. 1996 Auto antibodies to GAD65 and ICA512/IA-2 improve IDDM prediction in first-degree relatives with decreased first phase insulin response and ICA positivity. Autoimmunity. 24(Suppl 1):51.
26. Bach JF. 1994 Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopathol. 72:156-161.
27. Muir A, Ramiya V. 1996 New strategies in oral immunotherapy for diabetes prevention. Diabetes Metab Rev. 12:1-14.
28. Simone EA, Wegmann DR, Eisenbarth GS. 1999 Immunologic “vaccination” for the prevention of autoimmune diabetes (type 1A). Diabetes Care. 22(Suppl 2):B7-B15.
29. Atkinson MA, Leiter EH. 1999 The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med. 5:601-604.
30. Sadelain MW, Qin HY, Sumoski W, Parfrey N, Singh B, Rabinovitch A. 1990 Prevention of diabetes in the BB rat by early immunotherapy using Freund’s adjuvant. J Autoimmun. 3:671-680.
31. Sadelain MW, Qin HY, Lauzon J, Singh B. 1990 Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:583-589.
32. Harada M, Kishimoto Y, Makino S. 1990 Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes. 8:85-90.
33. Elias D, Reshef T, Birk OS, van der Zee R, Walker MD, Cohen IR. 1991 Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA. 88:3088-3091.
34. Muir A, Peck A, Clare-Salzler M, et al. 1995 Insulin immunization of non obese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest. 95:628-634.
35. Daniel D, Wegmann DR. 1996 Protection of non obese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA. 93:956-960.
36. Tisch R, Liblau RS, Yang XD, Liblau P, McDevitt HO. 1998 Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in non obese diabetic mice. Diabetes. 47:894-899.
37. Elliot J, Qin H, Bhatti S, et al. 1994 Immunization with the larger form of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes. 43:1494-1499.
38. Ramiya VK, Lan MS, Wasserfall CH, Notkins AL, Maclaren NK. 1997 Immunization therapies in the prevention of diabetes. J Autoimmun. 10:287-292.
39. Karges W, Hammond-McKibben D, Gaedigk R, Shibuya N, Cheung R, Dosch H-M. 1997 Loss of self-tolerance to ICA69 in non-obese diabetic mice. Diabetes. 46:1548-1556.
40. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. 1991 Suppression of diabetes in non obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA. 88:10252-10256.
41. Bergerot I, Fabien N, Maguer V, Thiovolet C. 1994 Oral administration of human insulin to NOD mice generates CD41 T cells that suppress adoptive transfer of diabetes. J Autoimmun. 7:655-663.
42. Ploix C, Bergerot I, Fabien N, Perche S, Moulin V, Thivolet C. 1998 Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes. Diabetes. 47:39-44.
43. Sai P, Damage C, Rivereau AS, Hoeltzel A, Gouin E. 1996 Prophylactic oral administration of metabolically active insulin entrapped in isobutyl cyanoacrylate nanocapsules reduces the incidence of diabetes in non obese diabetic mice. J Autoimmun. 9:713-722.
44. vonHerrath MG, Dyrberg T, Goldstone MBA. 1996 Oral insulin treatment suppresses viral-induced antigen-specific destruction of beta cells and prevent autoimmune diabetes in transgenic mice. J Clin Invest. 98:1324-1331.
45. Mordes JP, Schirf B, Roipko D, et al. 1996 Oral insulin does not prevent insulin-dependent diabetes mellitus in the BB rat. Ann NY Acad Sci. 778:418-421.
46. Bergerot I, Fabien N, Mayer A, Thivolet C. 1996 Active suppression of diabetes after oral administration of insulin is determined by antigen dosage. Ann N Y Acad Sci. 778:362-367.
47. Daniel D, Wegmann DR. 1996 Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes. Ann N Y Acad Sci. 778:371-372.
48. Maron R, Melican NS, Weiner HL. 1999 Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally-and nasally-treated NOD mice suppress diabetes. J Autoimmun. 12:251-258.
49. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K. 1996 Aerosol insulin induces regulatory CD8 g d T-cells that prevent murine insulin dependent diabetes. J Exp Med. 184:2167-2174.
50. Hutchings PR, Cooke A. 1995 Comparative study of the protective effect afforded by intravenous administration of bovine or ovine insulin to young NOD mice. Diabetes. 44:906-910.
51. Kaufman DL, Clare-Salzler M, Tian J, et al. 1993 Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin dependent diabetes. Nature. 366:69-72.
52. Vlahos WD, Seemayer TA, Yale JF. 1991 Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism. 40:825-829.
53. Daniel C, Grakoui A, Allen PM. 1998 Inhibition of an in vitro CD41 T cell alloresponse using altered peptide ligands. J Immunol. 160:3244-3250.
54. Karounos DG, Bryson JS, Colhen DA. 1997 Metabolically inactive insulin analogue prevents type 1 diabetes in prediabetic NOD mice. J Clin Invest. 100:1344-1348.
55. Elias D, Marcus H, Reshef T, Ablamunits V, Cohen IR. 1995 Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein. Eur J Immunol. 25:2851-2857.
56. Elias D, Cohen IR. 1995 Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes. 44:1132-1138.
57. Smerdon RA, Peakman M, Hussain MJ, Vergani D. 1993 Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology. 80:498 -501.
58. Coon B, An LL, Lindsay WJ, vonHerrath MG. 1999 DNA immunization to prevent autoimmune diabetes. J Clin Invest. 104:189-194.
59. Reddy S, Bibby NJ, Elliott RB. 1990 Early nicotinamide treatment in theNOD mouse: effects on diabetes and insulitis suppression and autoantibody levels. Diabetes Res. 15:95-102.
60. Kolb H, Burkhart V. 1999 Nicotinamide in type 1 diabetes: mechanism of action revisited. Diabetes Care. 22(Suppl 2):B16-B20.
61. Gale EA. 1996 Practice of nicotin amide trials in pre-type 1 diabetes. J Pediatr Endocrinol Metab. 9:375-379.
62. Karges W, Dosch H-M. 1996 Environmental factors: cow milk and others. In: Palmer JP, ed. Diabetes prediction, prevention and genetic counselling in IDDM. Chichester, UK: John Wiley and Sons Ltd.; 167-180.
63. Scott FW, Norris JM, Kolb H. 1996 Milk and type I diabetes: examining the evidence and broadening the focus. Diabetes Care. 19:379-383.
64. Scott FW, Cloutier HE, Kleemann R, et al. 1997 Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells. Diabetes. 46:589-598.
65. Malkani S, Nompleggi D, Hansen JW, Greiner DL, Mordes JP, Rossini AA. 1997 Dietary cow’s milk protein does not alter the frequency of diabetes in the BB rat. Diabetes. 46:1133-1140.
66. Elliott RB, Martin JM. 1984 Dietary protein: a trigger of insulin-dependent diabetes in the BB rat? Diabetologia. 26:297-299.
67. Karges W, Hammond-McKibben D, Cheung RK, et al. 1997 Immunological aspects of nutritional diabetes prevention in NOD mice. A Pilot study for the cow’s milk-based IDDM Prevention Trial. Diabetes. 46:557-564.
68. Reddy S, Bibby N, Elliott RB. 1990 Longitudinal study of islet cell antibodies and insulin auto antibodies and development of diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol. 81:400-405.
69. Karges W, Ilonen J, Robinson BH, Dosch H-M. 1995 Self and non-self antigen in diabetic autoimmunity: molecules and mechanisms. Mol Aspects Med. 16:79-213.
70. Elias D, Cohen IR. 1994 Peptide therapy for diabetes in NOD mice (see comments). Lancet. 343:704-706.
71. Titlbach M, Nouza K, Mullerova M, Pekarek J. 1988 Immuno diabetes in rabbits. Endocrinol Exp. 22:3-18.
72. Owens T, Sriram S. 1995 The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis (Review; 170 refs.). Neurol Clin. 13:51-73.
73. Geng L, Solimena M, Flavell RA, Sherwin RS, Hayday AC. 1998 Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease. Proc Natl Acad Sci USA. 95:10055-10060.
74. Gunaratnam L, Wiener S, Hammond-McKibben D, Cheung R, Dosch H-M. 1998 Precipitation of IDDM by the ICA69 T-cell epitope peptide Tep69. Diabetes. 47(Suppl 1):A34.
75. Bellmann K, Kolb H, Rastegar S, Jee P, Scott FW. 1998 Potential risk of oral insulin with adjuvant for the prevention of type 1 diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats. Diabetologia. 41:844-847.
76. Blanas E, Carbone FR, Allison J, Miller JFAP, Heath WR. 1996 Induction of autoimmune diabetes by oral administration of auto antigen. Science. 274:1707-1709.
77. Genain CP, Abel K, Belmar N, et al. 1996 Late complications of immune deviation therapy in a non-human primate. Science. 274:2054 -2056.
78. Hartmann B, Bellmann K, Ghiea I, Kleemann R, Kolb H. 1997 Oral insulin for diabetes prevention in non-obese mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant. Diabetologia. 40:902-909.
79. Petersen JS, Karounos D, Dyrberg T. 1999 Dose dependent effect of prophylactic insulin: high dose is critical for prevention of diabetes. Diabetologia. 42(Suppl 1):A8.
80. DiLorenzo TP, Graser RT, Ono T, et al. 1998 Major histo compatibility complex plus one-restricted T-cells are required for all but the end stages of diabetes development in non obese diabetic mice and use a prevalent T-cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci USA. 95:12538-12543.
81. Bergerot I, Ploix C, Petersen J, et al. 1997 A Cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA. 94:4610-4614.
82. Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC. 1996 Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol. 157:4230-4238.
83. Savola K, Sabbah E, Kulmala P, et al. 1998 Auto antibodies associated with type 1 diabetes mellitus persist after diagnosis in children. Diabetologia. 41:1293-1297.
84. Dosch H-M, Cheung RK, Karges W, Pietropaolo M, Becker DJ. 1999 Anergic and non-anergic autoreactive T cells persist past onset of autoimmune diabetes. J Immunol. In press.
85. Martin S, Schernthaner G, Nerup J, et al. 1991 Followup of cyclosporine A treatment in type 1 (insulin dependent) diabetes mellitus: lack of long-term effects. Diabetologia. 34:429-434.
86. De Filippo G, Carel JC, Boitard C, Bougneres PF. 1996 Long-term results of early cyclosporine therapy in juvenile IDDM. Diabetes. 45:101-104.
87. Carel JC, Boitard C, Eisenbarth G, Bach JF, Bougneres PF. 1996 Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children. J Autoimmun. 9:739-745.
88. Pozzilli P, Browne PD, Kolb H, The Nicotinamide Trialists. 1996 Correct analysis of nicotinamide in patients with recent onset insulin dependent diabetes. Diabetes Care. 19:1356-1363.
89. Elliott RB, Chase HP. 1991 Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia. 34:362-365.
90. Elliott RB, Pilcher CC, Ferguson DM, Stuart AW. 1996 A population based strategy to prevent insulin-dependent diabetes using nicotin amide. J Pediatr Endocrinol Metab. 9:501-509.
91. Lampeter EF, Klinghammer A, Scherbaum WA, et al. 1998 The Deutsche Nicotin amide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes. 47:980-984.
92. Shah SC, Malone JI, Simpson NE. 1989 A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med. 320:550-554.
93. The Diabetes Control, and Complications Trial Research Group. 1994 Effect of intensive diabetes treatment on the development and progression of longterm complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial. J Pediatr. 125:177-188.
94. Eisenbarth GS, Gianani R, Yu L, et al. 1998 Dual-parameter model for prediction of type 1 diabetes mellitus. Proc Assoc Am Phys. 110:126-135.
95. Keller RJ, Eisenbarth GS, Jackson RA. 1993 Insulin prophylaxis in individuals at high risk of Type 1 diabetes. Lancet. 341:927-928.
96. Fruchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG. 1998 Delay of type 1 diabetes in high-risk first-degree relatives by parenteral antigen administration: The Schwabing insulin prophylaxis pilot trial. Diabetologia. 41:436-441.
97. Schatz DA, Rogers DG, Brouchard BH. 1996 Prevention of insulin-dependent diabetes mellitus: An overview of three trials. Cleve Clin J Med. 63:270-274.
98. Greenbaum CJ, Kahn SE, Palmer JP. 1996 Nicotin amide’s effect on glucose metabolism in subjects at risk for IDDM. Diabetes. 45:1631-1634.
99. Bingley PJ, Caldas G, Bonfanti R, Gale EA. 1993 Nicotin amide and insulin secretion in normal subjects. Diabetologia. 36:675-677.
100. Gotfredsen GF, Buschard K, Frandsen EK. 1985 Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetesproned animals. Diabetologia. 28:933-935.
101. Like AA. 1989 Morphology and mechanisms of autoimmune diabetes as revealed by studies of the BB/Wor rat. In: Hanahan D, McDevitt HO, Cahill GJ, eds. Perspectives on the molecular biology and immunology of the pancreatic b cells. Cold Spring Harbor, NY: Current Communications in Molecular Biology; 81-91.
102. Gottlieb P, Handler E, Appel M, et al. 1991 Insulin treatment prevents diabetes but not thyroiditis in RT6-depleted resistant BB/Wor rats. Diabetologia. 34:296-300.
103. Atkinson MA, Maclaren NK, Leuchetta R. 1990 Insulitis and insulin dependent diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 39:933-937.
104. Thivolet CH, Goillot E, Bedossa P, et al. 1991 Insulin prevents adoptive transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetol. 34:314-319.
105. Ryan CM, Atchison J, Puczynski S, et al. 1990 Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin dependent diabetes mellitus. J Pediatr. 117:32-38.
106. Becker DJ, Suprasongsin C, Jarjour I, Arslanian S, Ryan C. 1997 Mild hypoglycemia induced cognitive dysfunction is independent of anxiety and is limited to diabetic subjects. Diabetologia. 40(Suppl 1):A241.
107. Semana G, Gausling R, Jackson RA, Hafler DA. 1999 T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J Autoimmun. 12:259-267.
108. Congia M, Patel S, Cope AP, DeVirgiliis S, Sonderstrup G. 1998 T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci U S A. 95:3833-3838.
109. Dosch H-M, Cheung RK, Pietropaolo M, Becker DJ. 1998 Do proinsulin-and IA-2 specific T cells mark progression of diabetic autoimmunity? Diabetes. 47(Suppl 1):A208.
110. Åkerblom HK, Knip M, Hyoty H, et al. 1997 Interaction of genetic and environmental factors in the pathogenesis of insulin-dependent diabetes mellitus. Clin Chim Acta. 257:143-156.
111. Perez-Bravo F, Carrasco E, Gutierrez-Lopez MD, Martinez MT, Lopez G, Garcia Delos Rios M. 1996 Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J Mol Med. 74:105-109.
112. Hammond-McKibben D, Dosch H-M. 1997 Cow milk, BSA and IDDM: can we settle the controversies? Diabetes Care. 20:897-901.
113. Akerblom HK, Savilahti E, Saukkonen TT, et al. 1993 The case for elimination of cow’s milk in early infancy in the prevention of Type 1 diabetes: The Finnish experience. Diabetes Metab Rev. 9:269-278.
114. Vaarala O, Saukkonen T, Savilahti E, Klemola T, Akerblom HK. 1995 Development of immune response to cow’s milk proteins in infants receiving cow’s milk or hydrolyzed formula. J Allerg Clin Immunol. 96:917-923.
115. Saukkonen T, Virtanen SM, Karppinen M, et al. 1998 Significance of cow’s milk protein antibodies as risk factor for childhood IDDM: interactions with dietary cow’s milk intake and HLA-DQB1 genotype. Diabetologia. 41:72-78.
116. Akerblom HK, Virtanen SM, Hamalainen A, et al. 1999 Emergence of diabetes-associated autoantibodies in the nutritional prevention of IDDM (TRIGR) project. Diabetes. In press.
117. Hahl J, Simell T, Ilonen J, Knip M, Simell O. 1998 Costs of predicting IDDM. Diabetologia. 41:79-85.
118. Norris JM, Beaty B, Klingensmith G, et al. 1996 Lack of association between early exposure to cow’s milk protein and b cell autoimmunity; Diabetes Autoimmunity Study in the Young (DAISY). J Am Med Assoc. 276:609-614.
119. Ziegler AG, Hummell M, Schenker M, Bonifacio E. 1999 Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 48:460-468.
120. Knip M, Karjalainen J, Akerblom HK. 1998 Islet cell antibodies are less predictive ofIDDMamong unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group. Diabetes Care. 21:1670-1673.
121. Ryan CM, Becker DJ. 1999 Hypoglycemia in children with type 1 diabetes: risk factors, cognitive function and management. Endocrinol Clin. In press.
122. Becker DJ, Ryan CM. 1999 Intensive diabetes therapy in childhood: is it achievable? Is it desirable? Is it safe? J Pediatr. 134:392-394.
123. Lipton R, LaPorte RE, Becker DJ, et al. 1990 Immunosuppressive therapy for the prevention of insulin-dependent diabetes: an epidemiologic perspective of benefits and risks. Diabetes Care. 13:776-784.